Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

He said, “Hey Joe, I’m getting these weird calls about semaglutide ... When I identified myself as a writer for Science News and asked if anyone would speak about their experiences ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

However, at the two-year, three-year, and four-year time points from the index date, those taking semaglutide had an increased risk for NAION (hazard ratios, 2.39, 2.44, and 2.05, respectively).

In India, there were 32 centres and 788 people enrolled. Semaglutide was initially approved in June 2021 for chronic weight management in those with obesity or overweight and at least one weight ...

Image Credit: Korawat photo shoot / Shutterstock.com Semaglutide is an incretin mimetic ... that necessitate further exploration in basic science research and clinical trials." ...